Published in J Hypertens on September 01, 2016
Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77
Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol (2007) 1.77
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. Neurology (1999) 1.65
Macro and microvasculature in hypertension: therapeutic aspects. J Hum Hypertens (2008) 1.53
Circulating adhesion molecules and carotid artery structural changes in patients with noninsulin-dependent diabetes mellitus. J Hum Hypertens (2003) 1.51
Early relapses after the first dose of natalizumab in active multiple sclerosis patients. Mult Scler (2008) 1.44
Hyponatraemia and seizure due to overdose of trazodone. BMJ (1992) 1.37
Modelling supply and demand of bioenergy from short rotation coppice and Miscanthus in the UK. Bioresour Technol (2010) 1.35
Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation (2001) 1.31
Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation (2001) 1.24
Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens (1995) 1.22
Yield and spatial supply of bioenergy poplar and willow short-rotation coppice in the UK. New Phytol (2008) 1.21
Changing prognosis of primary intracerebral hemorrhage: results of a clinical and computed tomographic follow-up study of 104 patients. Stroke (1988) 1.17
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler (2011) 1.16
Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J Immunol (1997) 1.15
Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology (2010) 1.15
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study. Mult Scler (2013) 1.12
Various ways of calculating echocardiographic left ventricular mass and their relative prognostic values. J Hypertens (1998) 1.12
HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun (2009) 1.09
Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens (1998) 1.08
Vascular structural and functional alterations before and after the development of hypertension in SHR. Am J Hypertens (1994) 1.02
Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine-needle aspiration cytology? Clin Endocrinol (Oxf) (2005) 1.01
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. Eur J Neurol (2012) 1.00
IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients. J Immunol (1999) 1.00
Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens (1992) 0.97
Variations of the perforin gene in patients with multiple sclerosis. Genes Immun (2008) 0.96
Von Recklinghausen's neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature. Minerva Endocrinol (2004) 0.96
Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain (1991) 0.95
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry (2005) 0.95
Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation (1995) 0.94
The effect of Bacille Calmette-Guérin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS. J Neurol (2003) 0.93
Small artery remodeling in diabetes mellitus. Nutr Metab Cardiovasc Dis (2009) 0.93
Vascular hypertrophy and remodeling in secondary hypertension. Hypertension (1996) 0.93
Left ventricular structural characteristics in Cushing's syndrome. J Hum Hypertens (1994) 0.92
The role of imaging in Graves' disease: a cost-effectiveness analysis. Eur J Radiol (2007) 0.92
Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms. Arterioscler Thromb Vasc Biol (2000) 0.92
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a. J Interferon Cytokine Res (1998) 0.91
Prevalence of parathyroid cysts by neck ultrasound scan in unselected patients. J Endocrinol Invest (2009) 0.90
The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens (1998) 0.90
Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry. Circulation (2001) 0.90
Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis. J Neuroimmunol (1998) 0.90
Microbe exposure, innate immunity and autoimmunity. Immunol Today (1999) 0.89
A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun (2007) 0.89
Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension (1998) 0.88
Production and expression of dTMP-enriched DNA of bacteriophage SP15. J Virol (1978) 0.87
Italian population yields world's largest twin registry. Nat Med (1997) 0.87
Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension. J Cardiovasc Pharmacol (1994) 0.87
Efficacy of low-dose captopril given twice daily to patients with essential hypertension uncontrolled by a beta blocker plus thiazide diuretic. J Int Med Res (1984) 0.86
Time course of apoptosis in small resistance arteries of spontaneously hypertensive rats. J Hypertens (2000) 0.84
Endothelial dysfunction in small resistance arteries of patients with non-insulin-dependent diabetes mellitus. J Hypertens (2001) 0.84
Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. Hypertension (1996) 0.84
Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension (2000) 0.84
Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension. Hypertension (1999) 0.83
Fine needle cytology of complex thyroid nodules. Eur J Endocrinol (2007) 0.83
Prognostic significance of left ventricular hypertrophy regression. Adv Exp Med Biol (1997) 0.83
Cost-effectiveness of fine-needle-aspiration cytology of thyroid nodules with intranodular vascular pattern using two different needle types. Endocr Pathol (2005) 0.83
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design. J Hum Hypertens (2012) 0.83
Structural association between the carotid artery and the left ventricle in a general population in Northern Italy: the Vobarno study. J Hypertens (1998) 0.82
Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study. J Hum Hypertens (2003) 0.82
T cell response to N-formylated peptides in humans. Eur J Immunol (2001) 0.82
Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry (1996) 0.82
Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension (1998) 0.82
Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins. Mult Scler (2011) 0.82
Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families. Eur J Hum Genet (1999) 0.82
Percutaneous intraductal sampling for cyto-histologic diagnosis of biliary duct strictures. Tumori (1999) 0.81
Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol (1998) 0.81
Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens (1997) 0.81
A controlled study of potential risk factors preceding exacerbation in multiple sclerosis. J Neurol Neurosurg Psychiatry (1995) 0.81
Flow-mediated dilatation of the brachial artery and left ventricular geometry in hypertensive patients. J Hypertens (2001) 0.81
Echocardiography in clinical practice: the burden of arterial hypertension. A multicenter Italian survey. J Hum Hypertens (2009) 0.81
Autologous peripheral blood stem cell transplantation in a patient with multiple sclerosis and concomitant Ph+ acute leukemia. Haematologica (1999) 0.81
In vivo study of polyurethane-coated Gianturco-Rosch biliary Z-stents. Cardiovasc Intervent Radiol (2000) 0.80
Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune disorders. Immunol Today (2000) 0.80
[Rare vascular complications of Behçet's disease (so-called angiobehçet)]. Schweiz Med Wochenschr (1989) 0.80
Serum elements and oxidative status in clinically isolated syndromes: imbalance and predictivity. Neurology (2011) 0.80
TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas. Diagn Mol Pathol (2000) 0.80
The smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatment. J Hypertens (2001) 0.80
Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism. J Endocrinol Invest (2010) 0.80